Dr. Lal Path Labs Ltd. (LALPATHLAB) fair value: what the stock is really worth
As of Nov 16, 2026: fair value (intrinsic value) of Dr. Lal Path Labs Ltd. stock ₹1,303, price ₹2,001, that is 34.9% below the price, quality 66 out of 100. Rating: overvalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Dr. Lal Path Labs Ltd.
LALPATHLAB · NSEExpensive (fair value 35% below the price), but solid company and rising price: meets 2 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 14, 2026.
How to read this chart
60‑month range ₹863.06 – ₹992,867 · fair‑value band ₹885.44 – ₹1,660 · the ₹2,001 price screens above the ₹1,303 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 14, 2026.
Every Wednesday you see whether Dr. Lal Path Labs is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Dr. Lal PathLabs Limited operates laboratories for carrying out pathological investigations in India and internationally.
Show moreShow less
The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It also offers phlebotomist training programs.
The company was founded in 1949 and is based in Gurugram, India.
Stock analysis
Dr. Lal Path Labs Ltd. (LALPATHLAB) currently trades at ₹2,001, while our model-based Fair Value estimate is ₹1,303, 35% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of ₹725.16 per share, and 0 of the 26 models we run sit above the ₹2,001 price.
Bear case: the Dividend Discount group reads lowest at ₹181.56, and 26 of the 26 models stay below the price. Data coverage for this calculation is high.
Scenario range: ₹885.44 (bear) to ₹1,660 (bull), the price of ₹2,001 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 66/100 (solid quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Dr. Lal Path Labs Ltd. reported revenue of ₹27.6B in FY2026 versus ₹20.9B in FY2022, a compound +7.3%/yr. Reported net income was ₹5.0B in FY2026, compounding +10.0%/yr from FY2022.
Key figures
Market cap ₹334B (≈ $3.5B) Mid · P/E ratio 57.4 · P/S ratio 11.0 · EPS (TTM) ₹34.87 · Dividend yield 0.6% · Net margin 19.2% · Return on equity 22.6% · Return on assets (EBIT) 21.1% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 83 out of 100 (medium confidence).
What moves the price
The share trades about 1% below its 52-week high and 54% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −10% fair-value upside, at −35%, LALPATHLAB screens richer than that median.
Fair Value models
All 26 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Growth Forecast
Compare Dr. Lal Path Labs Ltd. with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Diagnostics & Research · 150 stocks
Valuation Multiplesvs Diagnostics & Research median · lower = cheaper
Strength profile in five axes (Snowflake)
VALUE 0: the price sits above our fair-value range.
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Debt-to-equity by industry
- Price/FCF by industry
- PEG screener for stocks with fair value
- Undervalued stocks: Indian Stocks
- Valuation of the India market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Diagnostics & Research stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| WuXi AppTec Co 603259 | ¥144.41 | ¥164.66 | +14% | vs LALPATHLAB |
| IQVIA Holdings IQV | $265.12 | $291.63 | +10% | vs LALPATHLAB |
| Illumina, Inc ILMN | $207.01 | $227.71 | +10% | vs LALPATHLAB |
| Thermo Fisher Scientific Inc TMO | $700.22 | $686.04 | −2% | vs LALPATHLAB |
| Danaher Corporation DHR | $233.02 | $209.18 | −10% | vs LALPATHLAB |
| IDEXX Laboratories, Inc IDXX | $704.23 | $496.48 | −30% | vs LALPATHLAB |
| Lonza Group LONN | CHF 670.20 | CHF 259.80 | −61% | vs LALPATHLAB |
| Mettler-Toledo International Inc MTD | $1,739 | $655.06 | −62% | vs LALPATHLAB |
| Agilent Technologies, Inc A | $173.96 | $64.53 | −63% | vs LALPATHLAB |
| Waters Corporation WAT | $460.25 | $91.26 | −80% | vs LALPATHLAB |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Dr. Lal Path Labs Ltd. (LALPATHLAB) overvalued or undervalued?
What is the fair value of LALPATHLAB?
What is the quality score of LALPATHLAB?
What is the price target for Dr. Lal Path Labs Ltd. (LALPATHLAB)?
What is the Dr. Lal Path Labs Ltd. stock forecast for 2026?
What is the revenue of Dr. Lal Path Labs Ltd. (LALPATHLAB)?
Does Dr. Lal Path Labs Ltd. pay a dividend?
How much is the dividend of Dr. Lal Path Labs Ltd. (LALPATHLAB) and when is the ex-dividend date?
What growth is priced into Dr. Lal Path Labs Ltd. (LALPATHLAB)?
What discount rate (WACC) does the fair value of LALPATHLAB use?
What is a reverse DCF?
How much growth has Dr. Lal Path Labs Ltd. (LALPATHLAB) delivered so far?
How fast is the sector of Dr. Lal Path Labs Ltd. (LALPATHLAB) growing?
What is the free cash flow yield of Dr. Lal Path Labs Ltd. (LALPATHLAB)?
What is the intrinsic value of Dr. Lal Path Labs Ltd. (LALPATHLAB)?
Is Dr. Lal Path Labs Ltd. stock overvalued or undervalued in 2026?
Is fair value the same as the market price of LALPATHLAB?
How much is Dr. Lal Path Labs Ltd. worth?
What do the bullish and bearish scenarios say about LALPATHLAB?
What is the P/E ratio of LALPATHLAB?
How solid is the balance sheet of Dr. Lal Path Labs Ltd. (LALPATHLAB)?
How far is LALPATHLAB from its 52-week high?
Which stocks are comparable to Dr. Lal Path Labs Ltd.?
Is Dr. Lal Path Labs Ltd. stock attractive at the current price?
How is the fair value of LALPATHLAB calculated?
Is it still worth investing in stocks now?
What is the share price of Dr. Lal Path Labs Ltd. (LALPATHLAB)?
What should I pay attention to with Dr. Lal Path Labs Ltd. right now?
Where does the earnings growth of Dr. Lal Path Labs Ltd. (LALPATHLAB) come from?
Key figures of Dr. Lal Path Labs Ltd.
How large is the market capitalisation of Dr. Lal Path Labs Ltd. (LALPATHLAB)?
What is the P/S ratio of Dr. Lal Path Labs Ltd. (LALPATHLAB)?
What are the earnings per share of Dr. Lal Path Labs Ltd. (LALPATHLAB)?
What is the dividend yield of Dr. Lal Path Labs Ltd. (LALPATHLAB)?
What is the net margin of Dr. Lal Path Labs Ltd. (LALPATHLAB)?
What is the return on equity of Dr. Lal Path Labs Ltd. (LALPATHLAB)?
What is the EBIT return on assets of Dr. Lal Path Labs Ltd. (LALPATHLAB)?
What is the operating margin of Dr. Lal Path Labs Ltd. (LALPATHLAB)?
How fast is revenue growing at Dr. Lal Path Labs Ltd. (LALPATHLAB)?
How fast are earnings growing at Dr. Lal Path Labs Ltd. (LALPATHLAB)?
How much net cash does Dr. Lal Path Labs Ltd. (LALPATHLAB) hold?
Watch Dr. Lal Path Labs Ltd. in the live analysis
One click puts Dr. Lal Path Labs Ltd. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.